// Company Overview //
| Stock Name | 東陽光藥 |
|---|
| Stock Code | 06887 |
|---|
| Company Full Name | 東陽光藥 |
|---|
| Industry | 生物医药 |
|---|
| Principal Activities | 一家綜合性製藥公司，從事藥物的研發、生產和商業化，專注於感染、慢病及腫瘤等治療領域。 |
|---|
| Listing Date | 2025-08-07 |
|---|
| Listing Rules Era | Old Rules |
|---|
| Listing Rules Chapter | No data |
|---|
| Weighted Voting Rights (WVR) | No |
|---|
| Registered Address (Mainland China) | 中國廣東省東莞市松山湖園區工業北路1號 |
|---|
| Business Address (Hong Kong) | 香港灣仔皇后大道東248號大新金融中心40樓 |
|---|
| Place of Incorporation | No data |
|---|
| Listing Method | No data |
|---|
| Listing Board | Main Board |
|---|
| Website | hecpharm.com |
|---|
| Share Registrar | 卓佳证券登记有限公司 (Tricor Investor Services Limited) |
|---|
| Registrar Contact | No data |
|---|
| A-Share/US Dual Listing | No |
|---|
// Offering Information //
| Prospectus Date | 2025-06-30 |
|---|
| Offer Price | — |
|---|
// Valuation & Financials //
| Market Cap (at Offer Price) | No data |
|---|
// First Day Performance
| First Day Close | Loading... |
|---|
// Price Chart //
// Underwriting Syndicate
Reporting Accountant
畢馬威會計師事務所
// Cornerstone Investors //
No data
// Directors & Management //
| Chairman | 張英俊 |
|---|
| Company Secretary | 鄭程傑 |
|---|
No director data available.
// Major Shareholders //
| Major Shareholders & Holdings | 控股股東為張先生、郭女士、廣東東陽光科技等一組股東，緊隨上市後直接或間接控制本公司50.98%的投票權。 |
|---|
Disclaimer & Risk Warning
Site Nature: This website (cibo.qizai.ai) is an independent technology product showcase platform established by Panda Securities Limited (CE Number: BNC380). This website itself and all content displayed herein do not constitute and are not involved in any regulated activity or licensed service.
Not Investment Advice: The data on this page is automatically extracted from prospectus PDFs by AI and may contain omissions or errors. Some data is supplemented from HKEX New Listing Reports ([HKEX]). All information and data on this page are sourced from prospectuses and related historical documents, are not real-time data, and will not be automatically updated, reflecting historical information at the time of prospectus publication. All content is provided solely for AI tool analysis learning exchange and technical reference purposes, and absolutely does not constitute any investment advice, offer to buy or sell, solicitation, recommendation, or guarantee. The output of this AI analysis tool should not be interpreted as investment opinion.
Decision Responsibility: Users should make investment decisions based on their own independent judgment and consult independent licensed financial advisors when needed. Neither the Company nor this AI analysis tool shall bear any responsibility for any investment decisions made by users based on the information on this page.
Separation from Panda Securities Official Website: The content of this website is strictly distinct from the SFC-regulated licensed services provided by Panda Securities' official website (fafa.hk). No securities trading or account opening or other regulated operations can be conducted through this website.
Panda Securities Limited is a licensed corporation regulated by the Hong Kong SFC (CE Number: BNC380) and a Hong Kong Exchange Participant (Participant ID: 02229). Use of this website constitutes acceptance of this disclaimer.
